Merck & Co., Inc. — Director's Dealing 2018

Oct 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-10-02

Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-02	Common Stock	M	279850.0000	$36.5600	Acquired	971800.0630	Direct
2018-10-02	Common Stock	S	279850.0000	$72.0681	Disposed	691950.0630	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-02	Stock Option (right to buy)	$36.5600	M	279850.0000	Disposed	2021-05-03	Common Stock (279850.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock - 401(k) Plan	3962.3677	Indirect

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.17, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F3: Holdings include shares acquired in dividend reinvestment transactions.

F4: Includes shares acquired and dividends earned through July 9, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.

F5: The option became exercisable in equal installments on 5/4/2012, 5/4/2013 and 5/4/2014.